Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.
Quick take
A CMV blood test looks for evidence of infection with cytomegalovirus, a common herpes-family virus that often causes no symptoms in healthy people but can be important during pregnancy, after transplantation, in people with weakened immune systems, and in newborns suspected of congenital CMV. Adult blood testing most often uses CMV IgG and CMV IgM antibody tests; some situations require CMV DNA PCR, also called viral load or nucleic acid amplification testing.
- CMV IgG positive usually means you were infected with CMV at some point in your life; by itself, it does not show when infection happened.
- CMV IgM positive may suggest recent or active infection, but it can be misleading and should not be used alone to diagnose a primary CMV infection.
- CMV IgG avidity may help distinguish a more recent primary infection from a past infection, especially when pregnancy is involved.
- CMV PCR measures CMV genetic material in blood or another specimen and is commonly used for monitoring people who are immunocompromised, including many transplant recipients.
- Most blood draws need no fasting or special preparation, but tell your clinician if you are pregnant, immunocompromised, recently transfused, or being monitored after a transplant.
On this page
What does a CMV blood test measure?
Cytomegalovirus, or CMV, is a common virus. After a person is infected, CMV usually stays in the body for life in an inactive state and may reactivate later. For many healthy children and adults, infection is mild or unnoticed. Testing matters most when CMV could affect clinical decisions, such as in pregnancy, suspected congenital infection, organ or stem cell transplantation, HIV or other immune suppression, or a mono-like illness when Epstein-Barr virus testing is negative.
The phrase “CMV blood test” can refer to more than one laboratory method. Antibody tests look at your immune response to CMV. Molecular tests look for the virus’s genetic material. The right test depends on the question being asked: Have I ever had CMV?, Could this be a recent infection?, or Is CMV actively replicating at a level that needs monitoring or treatment?
According to the Centers for Disease Control and Prevention laboratory guidance, serologic tests that detect CMV IgG and IgM antibodies are widely available for people older than 12 months, and enzyme-linked immunosorbent assay methods are commonly used for antibody measurement. The CDC also emphasizes that congenital CMV cannot be diagnosed with IgG or IgM antibody testing in newborns; PCR testing on saliva with urine confirmation is the standard approach.
Who may need a CMV blood test?
CMV testing is not usually ordered as a routine screening test for every healthy adult. It is most useful when the result will change counseling, monitoring, or treatment. You may be offered a CMV blood test if you:
- Have fever, fatigue, sore throat, swollen glands, or a mononucleosis-like illness and other common causes have not explained your symptoms.
- Are pregnant and have symptoms, a known exposure, or ultrasound findings that raise concern for CMV infection.
- Are being evaluated before or after an organ transplant or stem cell transplant.
- Have a weakened immune system and symptoms that could be caused by CMV disease, such as fever, hepatitis, colitis, pneumonia, or eye involvement.
- Are a prospective transplant donor or recipient and your care team needs to know CMV immune status.
- Need follow-up of a previous CMV result, such as repeat IgG titers, IgG avidity, or PCR viral load monitoring.
MedlinePlus describes CMV tests as tools for diagnosing current, reactivated, or past infection in people at risk for complications, including people with weakened immune systems, recent transplant recipients, pregnant people with symptoms, and newborns with signs of infection.
Types of CMV tests and what each one answers
| Test | What it measures | Common use | Key limitation |
|---|---|---|---|
| CMV IgG antibody | Longer-term immune response to CMV | Shows past exposure or immune status; used in transplant risk assessment and pregnancy evaluation | A positive result does not show when infection happened |
| CMV IgM antibody | Antibody that may appear with recent infection | May be ordered with IgG when recent infection is suspected | Can be positive in reactivation or from cross-reactivity; not reliable alone |
| CMV IgG avidity | How strongly IgG antibodies bind to CMV | Helps estimate whether infection was more recent or more remote, especially in pregnancy | Intermediate results can be hard to interpret; timing matters |
| CMV DNA PCR / quantitative NAAT | CMV genetic material, often reported as viral load | Monitoring and diagnosis in immunocompromised patients and transplant recipients | Results vary by specimen type and assay; serial monitoring should use the same method when possible |
| Saliva or urine PCR in newborns | CMV DNA in infant saliva or urine | Diagnosis of congenital CMV when collected in the first 2–3 weeks of life | Blood antibody testing is not adequate for diagnosing congenital CMV |
CMV IgG
IgG is the antibody most often used to determine whether someone has ever been infected with CMV. A negative IgG generally means no detectable past infection, although very early infection may not yet have produced measurable antibody. A positive IgG means exposure occurred at some point, but it does not identify whether infection happened last month, years ago, or decades ago.
In some cases, paired IgG testing is more informative than a single result. If the first sample is IgG negative and a later sample becomes IgG positive, that seroconversion is evidence of recent primary infection. Some laboratories also compare titers from two samples collected weeks apart. The ARUP Consult CMV testing guide notes that paired IgG results showing seroconversion, or a fourfold or greater rise in titer, can provide clear evidence of recent primary infection.
CMV IgM
IgM can appear during a recent infection, but CMV IgM is not specific enough to stand alone. It may persist, appear with reactivation, or be falsely positive because of cross-reactivity. This is a major reason many clinicians interpret CMV IgM together with IgG, symptoms, timing, repeat testing, and sometimes IgG avidity.
This point is especially important in pregnancy. The American College of Obstetricians and Gynecologists states that routine serologic screening for CMV before or during pregnancy is not recommended and that IgM alone is inadequate for diagnosing primary infection. If you are pregnant and receive an unexpected positive IgM result, ask your obstetric clinician whether repeat testing, IgG avidity, maternal-fetal medicine consultation, or fetal evaluation is appropriate.
CMV IgG avidity
Avidity testing measures how tightly IgG antibodies bind to CMV. Early after a primary infection, IgG binding strength tends to be lower; over time, it matures and becomes higher. A low-avidity result may support a more recent primary infection, while high avidity generally supports infection further in the past. The CDC describes IgG avidity as a tool that, when combined with IgM, can help identify primary CMV infection more reliably than IgM alone.
Avidity is not a screening shortcut. It works best when interpreted with the date of symptoms, prior CMV results if available, gestational age if pregnant, and the laboratory’s own reference ranges. Intermediate avidity results may not give a clear answer.
CMV DNA PCR or viral load
CMV DNA PCR detects viral genetic material. A qualitative PCR reports whether CMV DNA is detected or not detected. A quantitative PCR reports an amount, often called viral load. PCR is particularly important for people with suppressed immune systems, because antibody responses may be unreliable and because the amount of CMV DNA can help guide monitoring and treatment decisions.
In transplant care, quantitative nucleic acid amplification testing is widely used to monitor CMV after transplantation, guide preemptive therapy, and assess response to antiviral treatment. However, viral load numbers are not interchangeable across all labs and specimen types. ARUP notes that identical specimens may vary substantially between platforms and recommends using the same quantitative assay and sample type for ongoing surveillance whenever possible. International transplant consensus guidance similarly emphasizes that thresholds depend on the transplant setting, specimen type, test characteristics, and local protocols.
How to prepare for a CMV blood test
Most CMV blood tests require a standard blood draw from a vein in your arm. Fasting is usually not needed for CMV IgG, IgM, avidity, or most CMV PCR blood testing. Unless your clinician orders other tests at the same time that do require fasting, you can generally eat and drink normally.
Before the test, tell the ordering clinician or laboratory if any of the following apply:
- You are pregnant, trying to conceive, or recently delivered.
- You have received an organ transplant, stem cell transplant, chemotherapy, biologic immune-suppressing medication, or high-dose steroids.
- You have HIV or another condition affecting immune function.
- You recently had a blood transfusion or received immune globulin.
- You are taking antiviral medication such as valganciclovir, ganciclovir, foscarnet, cidofovir, letermovir, or maribavir.
- You are repeating a CMV viral load for monitoring and need the same specimen type as prior tests.
During the draw, a healthcare professional cleans the skin, inserts a small needle into a vein, and collects blood into one or more tubes. The blood draw usually takes only a few minutes. Minor bruising, tenderness, or lightheadedness can occur. Serious complications from venipuncture are uncommon.
How to interpret CMV blood test results
CMV results should be interpreted in the context of why the test was ordered. A healthy adult with mild symptoms, a pregnant person, and a transplant recipient may all have “CMV testing,” but the meaning and next steps can be very different.
| Result pattern | Common interpretation | Possible next step |
|---|---|---|
| IgG negative, IgM negative | No detectable evidence of prior CMV infection; very early infection is still possible if exposure was recent | Repeat testing may be considered if symptoms or exposure timing suggest early infection |
| IgG positive, IgM negative | Past CMV infection is likely; no serologic evidence of recent primary infection | Usually no action in healthy adults; may be used for transplant risk or pregnancy counseling |
| IgG negative, IgM positive | Possible very recent infection or false-positive IgM | Repeat IgG/IgM and consider additional evaluation based on risk |
| IgG positive, IgM positive | Could be recent infection, reactivation, persistent IgM, or false-positive IgM | Consider IgG avidity, paired titers, PCR, or specialist input depending on context |
| Low IgG avidity with compatible IgM/IgG pattern | Supports more recent primary infection | Time-sensitive counseling is especially important in pregnancy |
| High IgG avidity | Supports infection in the more distant past | Usually lowers concern for very recent primary infection, but interpretation depends on timing |
| CMV PCR detected | CMV DNA is present in the tested specimen | In immunocompromised patients, clinicians may trend viral load and assess symptoms |
| CMV PCR not detected | CMV DNA was not detected above the assay’s limit in that specimen | May not rule out tissue-invasive disease in every situation; clinical context matters |
Why a positive IgG is not usually an emergency
Many people discover they are CMV IgG positive during pregnancy workup, transplant evaluation, fertility testing, or an unrelated lab panel. In most adults, IgG positivity simply means past infection. It does not mean you are contagious in a way that requires isolation, and it does not prove that current symptoms are from CMV.
Why IgM needs caution
CMV IgM is one of the most misunderstood CMV results. A positive IgM can understandably cause anxiety, but it is not a diagnosis by itself. False positives and non-primary infection patterns are common enough that clinicians often confirm with repeat serology, IgG avidity, PCR, or a specialist review before making major decisions.
What to ask after you receive results
- Which CMV test was performed: IgG, IgM, avidity, PCR, or a combination?
- Was the result qualitative, quantitative, or reported with an index value?
- What are this laboratory’s reference ranges?
- Does the result suggest past exposure, possible recent infection, or active viral replication?
- Should the same test be repeated, and if so, when?
- If PCR was done, should future viral loads use the same lab and specimen type?
- If pregnancy or immune suppression is involved, should a specialist be consulted?
Special situations: pregnancy and newborns
CMV deserves special attention in pregnancy because a primary infection during pregnancy can sometimes pass to the fetus. Still, routine CMV screening of all pregnant people is not recommended in the United States by major professional guidance, in part because IgM screening is difficult to interpret and because a positive antibody result does not reliably predict fetal infection or severity.
When maternal CMV infection is suspected, clinicians may use paired IgG testing, IgM interpreted cautiously, and IgG avidity. If fetal infection is a concern, amniotic fluid PCR may be discussed. The Society for Maternal-Fetal Medicine recommends diagnosing suspected primary maternal infection by IgG seroconversion or by positive IgM, positive IgG, and low IgG avidity, and notes that amniocentesis is the best prenatal diagnostic tool when performed at the appropriate gestational timing.
For newborns, timing is critical. The CDC states that testing to confirm congenital CMV must be done within 2 to 3 weeks after birth; after that window, it may not be possible to distinguish congenital infection from infection acquired after birth. The standard diagnostic approach is PCR on saliva, typically confirmed with urine. Blood antibody testing is not the right way to diagnose congenital CMV in a newborn.
Limitations and factors that can affect interpretation
- Timing matters. Antibodies take time to appear, and a single sample may be less informative than paired testing.
- IgM can mislead. It may be falsely positive or reflect reactivation rather than primary infection.
- Immunocompromised patients may not mount typical antibody responses. PCR-based testing is often more useful in this setting.
- PCR viral load depends on the specimen and method. Whole blood and plasma results are not always comparable, and different assays can yield different numbers.
- A negative blood PCR does not always exclude localized tissue disease. For example, suspected CMV colitis, pneumonia, retinitis, or central nervous system disease may require evaluation of the affected site.
- Reference ranges differ by laboratory. Always read the lab’s interpretation and discuss unexpected results with the ordering clinician.
How much does a CMV blood test cost?
The cost of a CMV blood test depends on the test type, ordering route, insurance coverage, and whether other services are billed with it. A single CMV IgG or IgM antibody test is usually less expensive than a quantitative CMV DNA PCR. Avidity testing may be ordered as an additional send-out test. If a clinician visit, specimen collection fee, lab handling fee, or separate venipuncture charge is required, the total amount you pay may be higher than the listed lab price.
| Cost factor | What to check before testing |
|---|---|
| Test type | Confirm whether you need IgG, IgM, IgG avidity, PCR viral load, or a panel. |
| Ordering pathway | Testing through a clinician, hospital lab, urgent care, or consumer lab marketplace may have different pricing. |
| Mandatory fees | Ask about blood draw fees, processing fees, physician order fees, and facility fees. |
| Insurance | Check whether the test is covered for your diagnosis code and whether the lab is in network. |
| Repeat testing | Pregnancy evaluation or viral-load monitoring may require more than one test, so estimate the total course of testing. |
| Turnaround time | Send-out avidity or PCR tests may take longer and may cost more than routine antibody testing. |
If you are paying out of pocket, compare the effective total cost, not just the advertised test price. That means adding the base laboratory price, any required clinician order or review fee, collection fee, shipping or processing fee, and any repeat-test cost that is likely based on your situation. For medically urgent scenarios, pregnancy concerns, transplant monitoring, or immune suppression, choosing the right test and timely interpretation is more important than selecting the lowest sticker price.
Practical next steps after a CMV result
- If you are healthy and IgG positive only: ask whether any follow-up is needed; often this simply documents past exposure.
- If IgM is positive: do not assume it proves a new infection. Ask whether repeat serology, IgG avidity, or PCR is appropriate.
- If you are pregnant: contact your obstetric clinician promptly for interpretation in relation to gestational age, prior results, symptoms, and ultrasound findings.
- If a newborn may have congenital CMV: testing should happen within the first 2 to 3 weeks of life, usually with saliva PCR and urine confirmation.
- If you are immunocompromised: ask whether CMV PCR viral load monitoring is needed and whether future tests should use the same lab and specimen type.
- If symptoms are severe: seek medical care rather than waiting for a routine outpatient result.
FAQs about CMV blood testing
Is a CMV blood test the same as a mono test?
No. Mononucleosis-like symptoms can be caused by Epstein-Barr virus, CMV, and other infections. A standard “mono spot” test does not diagnose CMV. If EBV testing is negative and symptoms fit, a clinician may order CMV IgG/IgM or other testing.
Do I need to fast before a CMV blood test?
Usually no. CMV antibody and PCR blood tests generally do not require fasting. If other blood tests are ordered at the same time, follow the preparation instructions for the full panel.
What does CMV IgG positive and IgM negative mean?
This pattern most often means past CMV infection without serologic evidence of a recent primary infection. In pregnancy, transplant evaluation, or immune suppression, the clinical meaning may be more specific, so review the result with the ordering clinician.
What does CMV IgM positive mean?
It can mean recent infection, but it can also reflect reactivation, persistent IgM, or a false-positive result. CMV IgM should not be interpreted alone, especially during pregnancy.
Can a CMV blood test tell exactly when I was infected?
Usually not from one sample. Paired IgG testing, IgG avidity, symptom timing, prior lab results, and sometimes PCR may help narrow the timing, but exact dating is often not possible.
Is CMV dangerous?
For most healthy people, CMV is mild or unnoticed. It can be serious for fetuses, newborns with congenital CMV, transplant recipients, and people with significant immune suppression.
Can congenital CMV be diagnosed with a newborn antibody blood test?
No. The CDC states that congenital CMV cannot be diagnosed with IgG or IgM antibody testing. Diagnosis generally requires PCR testing of saliva with confirmatory urine testing within the first 2 to 3 weeks after birth.
Why does my CMV PCR result have a number?
A quantitative PCR reports the amount of CMV DNA in the specimen. Clinicians may use trends in viral load to monitor risk or response to treatment, especially in transplant or immunocompromised patients. Small changes may not be meaningful, and results should be compared using the same assay and specimen type whenever possible.
Can I order a CMV blood test myself?
In many states, consumer-initiated lab testing may be available for CMV antibodies, but availability, ordering rules, and collection locations vary. If you are pregnant, immunocompromised, symptomatic, or being monitored after transplant, involve a clinician so the correct test is ordered and interpreted safely.
Sources
- CDC: Laboratory Testing for CMV and Congenital CMV
- CDC: CMV in Newborns
- MedlinePlus: Cytomegalovirus (CMV) Tests
- ARUP Consult: Cytomegalovirus—Choose the Right Test
- ACOG: Cytomegalovirus (CMV) in Pregnancy
- Society for Maternal-Fetal Medicine: Diagnosis and Antenatal Management of Congenital CMV Infection
- Mayo Clinic: CMV Infection—Diagnosis and Treatment
